XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Cinderalla is in this beautiful house call of absolutelty

<< Previous

Bullboard Posts

Next >>

Comment by SpaceLabson Jan 20, 2022 2:32pm

122 Views

Post# 34338617

RE:Cinderalla is in this beautiful house call of absolutelty

CTO should have been the CEO to move this.

AB42 Failed to Net a great one in Bow ! why?

MenInRedDresses wrote: When does Mr Potatoe man put on a suit and deal with the MR/Miss Mess of this plague? Revenue cough cough, numbers, cough cough. Now tell me about financials and future fundamentals with out telling me about future financials and downfall fundamentals? See as one of this biggest Corp with your small bugged out eyes, WE As share holders want to see some sort of value? And the dollar store isn't an option for any closure comprondae?

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December